TRIBE; tyrosine kinase inhibitor therapy in renal-cell carcinoma: immune biomarker evaluation
Authors
Villa, ShaunPillai, Manon
Graham, Donna
Kilgour, Elaine
Overton, Nicola LD
Vasudev, N
Hughes, A
Walker, A
Dransfield, S
Thistlethwaite, Fiona C
Affiliation
Cancer Imaging Centre, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, LondonIssue Date
2018
Metadata
Show full item recordCitation
Villa S, Pillai M, Graham D, Kilgour E, Overton N, Vasudev N, et al. TRIBE; Tyrosine kinase inhibitor therapy in renal-cell carcinoma: Immune biomarker evaluation. Ann Oncol. 2018;29(suppl_6):20.Journal
Annals of OncologyDOI
10.1093/anonc/mdy315.008Additional Links
https://dx.doi.org/10.1093/anonc/mdy315.008Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/anonc/mdy315.008